STADA ARZNEIMITTEL NPV(REGD) (VINKULIERT) (NASDAQ:STDAF)‘s stock had its “neutral” rating reaffirmed by analysts at DZ Bank AG in a research note issued to investors on Friday.

Separately, Zacks Investment Research downgraded shares of STADA ARZNEIMITTEL NPV(REGD) (VINKULIERT) from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 15th.

Shares of STADA ARZNEIMITTEL NP (NASDAQ:STDAF) opened at 59.45 on Friday. The company has a market cap of $3.74 billion and a PE ratio of 29.09. STADA ARZNEIMITTEL NP has a 52 week low of $40.75 and a 52 week high of $62.20. The company has a 50 day moving average of $57.83 and a 200 day moving average of $53.03.

Your IP Address:

5 Day Chart for NASDAQ:STDAF

Receive News & Ratings for STADA ARZNEIMITTEL NPV(REGD) (VINKULIERT) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STADA ARZNEIMITTEL NPV(REGD) (VINKULIERT) and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit